SYS-CON MEDIA Authors: Sandi Mappic, Eric Brown, RealWire News Distribution, Kevin Benedict, Jason Bloomberg

News Feed Item

Swiss Consul General to Sponsor Growth Capital Expo Reception and Keynote on Behalf of Orphan Drug Foundation

LAS VEGAS, NV -- (Marketwired) -- 03/28/14 -- Growth Capital Expo is pleased to announce that the Consul General of Switzerland will sponsor the Welcome Reception for attendees of the IPO Boot Camp and Growth Capital Expo on April 29, 2014, from 6:00 - 7:30 pm in the Palace I ballroom at Caesars Palace, Las Vegas.

The Consul General is hosting the reception on behalf of Orphanbiotec, a Zurich-based research foundation dedicated to funding research and development, and partnering with pharmaceutical companies to ensure the provision of drugs for a variety of different rare diseases.

Julius Anderegg, the Consul General of Switzerland, will attend the reception and introduce Dr. Frank Grossman, Orphanbiotec's chief executive officer, who will discuss the many diseases that disproportionately affect children, yet research into their treatment attracts little investment from traditional capital sources due to their perceived lack of profitability.

Dr. Grossman will be the keynote speaker on the following opening day main session of the Growth Capital Expo 2014, speaking about the foundation's mission and achievements in advancing treatments for rare diseases, and its partnerships with private-sector drug development companies to obtain financing for research, development and distribution of treatment compounds for rare diseases.

"Today's pharmaceutical research for new medicinal active ingredients is very expensive and tedious," explains Dr. Grossman. "Despite recent developments, current and urgent questions remain open in healthcare. We are convinced that in addition to traditional finance, there will be additional intensive research and alternative approaches, to be able to respond to the future challenges of healthcare. Patients with a rare disease have the right to treatment."

The reception will kick-off the Expo ahead of the event's general session opening on April 30, and is open to all attendees. The reception will include hors d'oeuvres and a hosted bar.

"We are honored to have Mssr. Anderegg and Dr. Grossman join us to discuss their important work in the area of orphan disease research," said Shelly Kraft, Founder of SNN, Inc. and co-host of the Growth Capital Expo. "Dr. Grossman's devotion to raising awareness for rare orphan diseases is both inspirational and quite personal. There is an opportunity for all of us in the emerging growth capital market to play a part in developing these desperately needed treatments and ensuring their availability to the patients who need them."

If you would like to register to attend the Growth Capital Expo, please follow the link provided: https://www.growthcapitalexpo.com/register/

Stay connected for updates from Growth Capital Expo:

Facebook: Growth Capital Expo

Twitter: @GrowthCapExpo #GCE2014 #LasVegas

StockTwits: @GrowthCapExpo

Website: www.GrowthCapitalExpo.com

About Growth Capital Expo

The Growth Capital Expo is a three-day conference organized by SNN Inc., a global multimedia financial news and publishing company that provides self-directed investors information on selected small and microcap public companies; and Market Nexus Media, who publishes news and research, and produces events for companies and capital providers in high-growth markets.

The Growth Capital Expo brings together the best ideas, the most promising companies and the top deal makers in emerging growth finance for three days of education and networking in the nation's premier destination for meetings and entertainment. Join the top growth company executives, investors and finance specialists focused on the pre-IPO and public micro-cap market for an unparalleled experience in education, networking and deal making.

Website: www.GrowthCapitalExpo.com

Robert Kraft
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.